PT  - JOURNAL ARTICLE
AU  - Naik, Shivdas
AU  - Soneja, Manish
AU  - Haldar, Soumendra
AU  - Mundadan, Netto George
AU  - Garg, Prerna
AU  - Mittal, Ankit
AU  - Desai, Devashish
AU  - Trilangi, Praveen Kumar
AU  - Chakraborty, Sayan
AU  - Begam, Nazneen Nahar
AU  - Bhattacharya, Bisakh
AU  - Maher, Ganesh
AU  - Kumar, Swathi S
AU  - Kirthana, J
AU  - Arunan, Bharathi
AU  - Gupta, Ankesh
AU  - Mahishi, Niranjan
AU  - Rajanna, Chaitra
AU  - Parsoon, Prateek
AU  - Kumar, Nikhil A
AU  - Maharatna, Sayan
AU  - Bhattacharya, Akashneel
AU  - Keri, Vishakh C
AU  - Samed, Sameer A
AU  - Adarsh, AK
AU  - Shareef, Imtiyaz
AU  - Ravela, Neeren
AU  - Swain, Satish
AU  - Sarda, Radhika
AU  - Kadnur, Harshith B
AU  - Dudhwal, Ashok
AU  - Agarwal, Ayush
AU  - Vedula, Kartik
AU  - Gupta, Ashish
AU  - Agarwal, Shubham
AU  - Anand, R
AU  - Lalikar, Pratima
AU  - Jagtap, Pallavi
AU  - Premjeet, B
AU  - Kodan, Parul
AU  - Sethi, Prayas
AU  - Ray, Animesh
AU  - Jorwal, Pankaj
AU  - Kumar, Arvind
AU  - Nischal, Neeraj
AU  - Sinha, Sanjeev
AU  - Biswas, Ashutosh
AU  - Wig, Naveet
TI  - Post COVID-19 sequelae: A prospective observational study from Northern India
AID  - 10.1101/2021.06.28.21259658
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.28.21259658
4099  - http://medrxiv.org/content/early/2021/07/01/2021.06.28.21259658.short
4100  - http://medrxiv.org/content/early/2021/07/01/2021.06.28.21259658.full
AB  - Background Long COVID, or post-COVID-19 sequelae, is being seen in a growing number of patients reporting a constellation of symptoms, both pulmonary and extrapulmonary. Studies on COVID-19 recovered patients are scarce. Thus, there is a need to add granularity to our existing knowledge about the course and long-term effects of the infection.Aim To describe the clinical details and risk factors of post-COVID sequelae in the North Indian population.Method This prospective observational study was conducted at a tertiary healthcare centre in Northern India between October 2020 to February 2021. Patients aged >18 years with a confirmed COVID-19 disease were recruited after at least two weeks of diagnosis and interviewed for any post-COVID-19 symptoms.Results Of 1234 patients recruited, who were followed up for a median duration of 91 days (IQR: 45-181 days), 495 (40.11%) patients had symptoms. In 223 (18.1%) patients, the symptoms resolved within four weeks, 150 (12.1%) patients had symptoms till twelve weeks, and 122 (9.9%) patients had symptoms beyond twelve weeks of diagnosis of COVID-19. Most common long COVID-19 symptoms included myalgia (10.9%), fatigue (5.5%), shortness of breath (6.1%), cough (2.1%), disturbed sleep (1.4%), mood disturbances (0.48%) and anxiety (0.6%). The major determinants of developing post-COVID-19 symptoms in the patients were hypothyroidism and the severity of the disease.Conclusion Most often, patients complain of myalgias, fatigue, dyspnoea, cough and disturbed sleep. Patients who are hypothyroid or have recovered from moderate to severe COVID-19 are at higher risk of developing post-COVID sequelae. Therefore, a multidisciplinary approach is required to diagnose and manage COVID-19 recovered patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was cleared by the institutional ethics committee of AIIMS, New Delhi (IECPG/162/4/2020)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe data is available with the first author and can be produced on a reasonable request